Sun Pharmaceutical Industries BSE & NSE have climbed more than 4 percent in early trade on Wednesday After Company told that US drug regulator has accepted a new drug application for OTX-101, used in treating dry eye disease.
The Sun Pharma Share is trading above 4 percent Rs 565. Shares of the company opened at Rs 545 and touched a high and low of Rs 559.30 and Rs 543.15, respectively, in trade so far.
Sure Shot Trading Advice
@Intraday Trader can Buy Sun Pharmaceutical Industries Above 565 for targets 570 Stop Loss 575 Stop Loss 557.